

The chairman of Verona Pharma increased his stake in the company following Monday's news that the biotechnology firm has dosed its first group of volu...


Verona Pharma said the first group of volunteers have been dosed with its new nebulised formulation of its RPL554 product as part of a Phase I/II clin...